Advertisement

Gastroenterologia Japonica

, Volume 18, Issue 6, pp 525–529 | Cite as

Cholinergic independent dopaminergic regulation of motilin release in man

  • Akihiro Funakoshi
  • Masahiro Matsumoto
  • Kensaku Sekiya
  • Itsuro Nakano
  • Hirotsugu Shinozaki
  • Hiroshi Ibayashi
Original Article
  • 12 Downloads

Summary

This study investigated the dopaminergic control of motilin secretion in normal volunteers. Dopamine infusion caused a significant decline of plasma motilin levels, but had no effect on human pancreatic polypeptide (hpp) secretion. Dopamine antagonism with domperidone resulted in a significant elevation of motilin 10 and 20 min after the drug administration, and a significant elevation of hpp at 20 and 30 min. Atropine suppressed the basal levels of motilin and hpp but did not alter the increment of motilin levels after domperidone administration, while atropine suppressed domperidone induced secretory response of hpp.

These results suggest that dopaminergic mechanisms exert a tonic inhibitory effect on motilin secretion in normal subjects.

Key words

dopaminergic regulation motilin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Brown JC, et al: Effect of duodenal alkalinization on gastric motility. Gastroenterology 50: 333, 1966PubMedGoogle Scholar
  2. 2).
    Brown JC, Parkes CO: Effect on fundic pouch motor activity of stimulatory and inhibitory fractions separated from pancreozymin. Gastroenterology 53: 731, 1967PubMedGoogle Scholar
  3. 3).
    Brown JC, et al: Motilin, a gastric motor activitystimulating polypeptide: final purification, amino acid composition, and C-terminal residues. Gastroenterology 62: 401, 1972PubMedGoogle Scholar
  4. 4).
    Brown JC, et al: The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol 49: 399, 1971PubMedGoogle Scholar
  5. 5).
    Itoh Z, et al: Effect of synthetic motilin on gastric motor activity in conscious dogs. Am J Dig Dis 22: 813, 1977CrossRefGoogle Scholar
  6. 6).
    Lee KY, et al: Radioimmunoassay of motilin: validation and studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of dog. Am J Dig Dis 23: 789, 1978PubMedCrossRefGoogle Scholar
  7. 7).
    Itoh Z, et al: Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol (Suppl 39) 11:93, 1976Google Scholar
  8. 8).
    Lux G, et al: 13-Nle-motilin and interdigestive motor and electrical activity of human small intestine. Gastroenterology 74: 1058, 1978Google Scholar
  9. 9).
    Chey WY, Lee KY: Motilin, in Clinics in gastroenterology Vol 9, by Creutzfeldt W, London, 1980, p 645Google Scholar
  10. 10).
    Lee KY, et al: Cholinergic influence on release and action of motilin in dogs. Gastroenterology 80: 1206, 1981Google Scholar
  11. 11).
    Chey WY, et al: Endogenous plasma motilin concentration and interdigestive myoelectric activity of the canine duodenum, in Gut Hormones by Bloom SR, London and New York, 1978, p 355Google Scholar
  12. 12).
    You CH, et al: Studies on plasma motilin concentration and interdigestive motility of the duodenum in humans. Gastroenterology 79: 62, 1980PubMedGoogle Scholar
  13. 13).
    Van Neutin JM, et al: Inhibition of dopamine receptors in the stomach: an explanation of the gastrointestinal properties of domperidone. Life Sci 23: 453, 1978CrossRefGoogle Scholar
  14. 14).
    Delitala G, et al: Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man. J Clin Endocrinol Metab 50: 1127, 1980PubMedGoogle Scholar
  15. 15).
    Schwartz TW, et al: Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61: 781, 1978PubMedCrossRefGoogle Scholar
  16. 16).
    Laduron PM, Leysen JE: Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28: 2161, 1979PubMedCrossRefGoogle Scholar
  17. 17).
    Cooke RD, et al: Prevention of postoperative nausea and vomiting by domperidone. South Afr Med J 56: 827, 1979Google Scholar
  18. 18).
    Tanaka A, et al: Motilin. Nihon Rinsho 38: 1187, 1980Google Scholar
  19. 19).
    Matsumoto M, et al: Plasma human pancreatic polypeptide response in chronic pancreatitis. Gastroenterologia Jpn 17: 26, 1982Google Scholar
  20. 20).
    Thorner MO: Dopamine is an important neurotransmitter in the autonomous nervous system. Lancet 1: 662, 1975PubMedCrossRefGoogle Scholar
  21. 21).
    Baudry M, et al:3 H-Domperidone: a selective ligand for dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol 308: 231, 1979PubMedCrossRefGoogle Scholar
  22. 22).
    Costall B, et al: Neuropharmacological studies on the neuroleptic potential of domperidone (R33812). J Pharm Pharmacol 28: 2161, 1979Google Scholar
  23. 23).
    Fragen RJ, Caldwell N: Antiemetic effectiveness of intramuscularly administered domperidone. Anesthesiology 51:460, 1979PubMedCrossRefGoogle Scholar
  24. 24).
    Berger D, et al: The effect of adrenergic receptor blockade on the exercise induced rise in pancreatic polypeptide in man. J Clin Endocrinol Metab 50: 33, 1980PubMedCrossRefGoogle Scholar
  25. 25).
    Sowers JR, et al: Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab 54: 869, 1982PubMedGoogle Scholar
  26. 26).
    Valenzuela JE: Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 71: 1010, 1976Google Scholar

Copyright information

© The Japanese Society of Gastroenterology 1983

Authors and Affiliations

  • Akihiro Funakoshi
    • 1
  • Masahiro Matsumoto
    • 1
  • Kensaku Sekiya
    • 1
  • Itsuro Nakano
    • 1
  • Hirotsugu Shinozaki
    • 1
  • Hiroshi Ibayashi
    • 1
  1. 1.Third Department of Internal MedicineKyushu UniversityFukuokaJapan

Personalised recommendations